Cutia Therapeutics Files Director List with HKEX

Reuters

Dec 30, 2025

Cutia <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Files Director List with HKEX

Cutia Therapeutics has filed an updated list of directors with the Hong Kong Stock Exchange. The Board consists of Executive Directors Ms. Zhang Lele and Mr. Huang Yuqing; Non-executive Directors Dr. Chen Lian Yong, Dr. Xie Qin, Mr. Lu Minfang, and Ms. Yang Yunxia; and Independent Non-executive Directors Mr. Chung Ming Kit, Mr. Zhang Zhisong, and Mr. Ye Xiaoxiang. Regarding committee memberships, Mr. Chung Ming Kit serves as Chairman of the Audit Committee, with Mr. Zhang Zhisong and Mr. Ye Xiaoxiang as members. Mr. Ye Xiaoxiang chairs the Remuneration Committee, with Mr. Chung Ming Kit and Dr. Chen Lian Yong as members. Dr. Chen Lian Yong is Chairman of the Nomination Committee, joined by Dr. Xie Qin, Mr. Chung Ming Kit, Mr. Zhang Zhisong, and Mr. Ye Xiaoxiang as members.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cutia Therapeutics published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251230-11970268), on December 30, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2595605517"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2595605517\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2595605517?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-30 16:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2595605517","market":"nz","top_or_hot":-1,"title":"Cutia Therapeutics Files Director List with HKEX","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Cutia <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Files Director List with HKEX\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Cutia Therapeutics has filed an updated list of directors with the Hong Kong Stock Exchange. The Board consists of Executive Directors Ms. Zhang Lele and Mr. Huang Yuqing; Non-executive Directors Dr. Chen Lian Yong, Dr. Xie Qin, Mr. Lu Minfang, and Ms. Yang Yunxia; and Independent Non-executive Directors Mr. Chung Ming Kit, Mr. Zhang Zhisong, and Mr. Ye Xiaoxiang. Regarding committee memberships, Mr. Chung Ming Kit serves as Chairman of the Audit Committee, with Mr. Zhang Zhisong and Mr. Ye Xiaoxiang as members. Mr. Ye Xiaoxiang chairs the Remuneration Committee, with Mr. Chung Ming Kit and Dr. Chen Lian Yong as members. Dr. Chen Lian Yong is Chairman of the Nomination Committee, joined by Dr. Xie Qin, Mr. Chung Ming Kit, Mr. Zhang Zhisong, and Mr. Ye Xiaoxiang as members.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cutia Therapeutics published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251230-11970268), on December 30, 2025, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cutia Therapeutics Files Director List with HKEX</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCutia Therapeutics Files Director List with HKEX\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-12-30 16:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Cutia <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Files Director List with HKEX\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Cutia Therapeutics has filed an updated list of directors with the Hong Kong Stock Exchange. The Board consists of Executive Directors Ms. Zhang Lele and Mr. Huang Yuqing; Non-executive Directors Dr. Chen Lian Yong, Dr. Xie Qin, Mr. Lu Minfang, and Ms. Yang Yunxia; and Independent Non-executive Directors Mr. Chung Ming Kit, Mr. Zhang Zhisong, and Mr. Ye Xiaoxiang. Regarding committee memberships, Mr. Chung Ming Kit serves as Chairman of the Audit Committee, with Mr. Zhang Zhisong and Mr. Ye Xiaoxiang as members. Mr. Ye Xiaoxiang chairs the Remuneration Committee, with Mr. Chung Ming Kit and Dr. Chen Lian Yong as members. Dr. Chen Lian Yong is Chairman of the Nomination Committee, joined by Dr. Xie Qin, Mr. Chung Ming Kit, Mr. Zhang Zhisong, and Mr. Ye Xiaoxiang as members.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cutia Therapeutics published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251230-11970268), on December 30, 2025, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02487","symbol_name":"科笛-B","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nNDL1z0XbG:1","article_id":"2595605517","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2595605517","pubTimestamp":1767083721,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Cutia Therapeutics has filed an updated list of directors with the Hong Kong Stock Exchange. The Board consists of Executive Directors Ms. Zhang Lele and Mr. Huang Yuqing; Non-executive Directors Dr. Chen Lian Yong, Dr. Xie Qin, Mr. Lu Minfang, and Ms. Yang Yunxia; and Independent Non-executive Directors Mr. Chung Ming Kit, Mr. Zhang Zhisong, and Mr. Ye Xiaoxiang. Regarding committee memberships, Mr. Chung Ming Kit serves as Chairman of the Audit Committee, with Mr. Zhang Zhisong and Mr. Ye Xiaoxiang as members. Mr. Ye Xiaoxiang chairs the Remuneration Committee, with Mr. Chung Ming Kit and Dr. Chen Lian Yong as members. Dr. Chen Lian Yong is Chairman of the Nomination Committee, joined by Dr. Xie Qin, Mr. Chung Ming Kit, Mr. Zhang Zhisong, and Mr. Ye Xiaoxiang as members.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02487":"科笛-B","BK1161":"生物科技"},"translate_title":"Cutia Therapeutics向港交所提交董事名单","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02487":0.9},"content_text":"Cutia Therapeutics Files Director List with HKEX\n    \n\n        Cutia Therapeutics has filed an updated list of directors with the Hong Kong Stock Exchange. The Board consists of Executive Directors Ms. Zhang Lele and Mr. Huang Yuqing; Non-executive Directors Dr. Chen Lian Yong, Dr. Xie Qin, Mr. Lu Minfang, and Ms. Yang Yunxia; and Independent Non-executive Directors Mr. Chung Ming Kit, Mr. Zhang Zhisong, and Mr. Ye Xiaoxiang. Regarding committee memberships, Mr. Chung Ming Kit serves as Chairman of the Audit Committee, with Mr. Zhang Zhisong and Mr. Ye Xiaoxiang as members. Mr. Ye Xiaoxiang chairs the Remuneration Committee, with Mr. Chung Ming Kit and Dr. Chen Lian Yong as members. Dr. Chen Lian Yong is Chairman of the Nomination Committee, joined by Dr. Xie Qin, Mr. Chung Ming Kit, Mr. Zhang Zhisong, and Mr. Ye Xiaoxiang as members.\n      \n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cutia Therapeutics published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251230-11970268), on December 30, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}